Anaemia in pregnancy is associated with advanced HIV disease

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Nandlal, Vikesh ^a   Moodley, Dhayendre ^a,c   Grobler, Anneke ^c   Bagratee, Jayanthilall ^a   Maharaj, Niren R ^a   Richardson, Paul ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FETUS OUTCOME; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; COMPLICATION; DISEASE COURSE; HIV INFECTIONS; MULTIVARIATE ANALYSIS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; URINARY TRACT INFECTIONS;

ANEMIA; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; URINARY TRACT INFECTIONS; ZIDOVUDINE;

EID: 84907203365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106103     Document Type: Article

References (28)

1. World Health Organization (WHO) (2011) Micronutrient deficiencies. Iron deficiency anemia. www.who.int.www.who.int/nutrition/topics/ida/en/index.html. Accessed 2011.
2. Johnson-Wimbley TD, Graham DY (2011 Diagnosis and management of iron deficiency anemia in the 21st century. Ther Adv Gastroenterol 4(3): 177-184.
3. Gangopadhyay E (2011) Anaemia and pregnancy: A link to maternal chronic diseases. Int J Gynaecol Obstet 115: 11-15.
4. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, et al. (2013) Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 346: f3443. Doi: 10.1136/bmj.f3443.
5. Belperio PS, Rhew DC (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med (Suppl 7A): 27S-43S.
6. Lundgren JD, Mocroft A (2003) Anemia and survival in human immunodeficiency virus. Clin Infect Dis (Suppl 4): S297-S303.
7. Srasuebkul P, Lim PL, Lee MP, Kumarasamg N, Zhou J, et al. (2009) Short term clinical disease progressive in HIV-infected patients receiving combination therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis 48(7): 940-950.
8. National Department of Health, South Africa (2012) Saving Mothers 2008-2010: Fifth Report on the Confidential Enquiries into Maternal Deaths in South Africa. NDoH, Pretoria: Statement Office.
9. Spiga MG, Weidner DA, Trentesaux C, LeBoeuf RD, Sommadossi JP (1999) Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erthroid progenitor cells. Antivir Res 44: 167-177.
10. Sartorius BKD, Chersich MF, Mwaura M, Meda N, Temmerman M, et al. (2013) Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother to child transmission. BMC Infec Dis 13: 522.
11. Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, et al. (2011) Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes. AIDS 25(13): 1611-1618.
12. Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, et al. (2012) Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet 379(9812): 221-228.
13. National Department of Health, South Africa (2008) Policy and Guidelines for the Implementation of the PMTCT Programme. Available: http://southafrica.usembassy.gov/root/pdfs/2008-pmtct.pdf. Accessed 27 September 2012.
14. World Health Organisation (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organisation.(WHO/NMH/NHD/MNM/11.1) http://www.who.int/vmnis/indicators/haemoglobin.pdf.Accessed August 2014.
15. Massawe SN, Urassa EN, Nystrom L, Lindmark G (1999) Effectiveness of primary level antenatal care in decreasing anemia at term in Tanzania. Acta Obstet Gynecol Scand 78: 573-579.
16. World Health Organization (2001) Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva, World Health Organization. http://www.who.int/nutrition/publications/micronutrients/anaemia-iron-deficiency/WHO-NHD-01.3/en/. Accessed August 2014.
17. Levine AM, Berhane K, Masri-Lavine L, Sanchez M, Young M, et al. (2001) Prevalence and correlates of anaemia in a large cohort of HIV-infected women: Women's Interagency HIV study. J Acquir Immune Defic Syndr 26: 28-35.
18. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, et al. (1999) Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 13: 943-950.
19. Moyle G (2002) Anaemia in persons with HIV infection: prognostic marker of contribution to morbidity. AIDS Rev 4(1): 13-20.
20. Lewis DK, Whitty CJ, Walsh AL, Epino H, Broek NR, et al. (2005) Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalence. Trans R Soc Trop Med Hyg 99: 561-567.
21. Ziske J, Kunz A, Sewangi J, Lau I, Dugange F, et al. (2013) Hematological changes in women and infants exposed to a ZDV-Containing Regimen for prevention of mother-to-child transmission of HIV in Tanzania. PLoS ONE 8(2): e55633. Doi:10.1371/journal.pone.0055633.
22. Villamor E, Dreyfuss ML, Baylin A, Msamanga G, Fawzi WW (2004) Weight loss during pregnancy is associated with adverse pregnancy outcomes among HIV-1 infected women. J Nutr 134(6): 1424-1431.
23. Schieve LA, Handler A, Hershow R, Persky V, Davis F (1994) Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health 84(3):405-410.
24. Marchant T, Schellenberg JA, Nathan R, Abdulla S, Mukasa O, et al. (2004) Anaemia in pregnancy and infant mortality in Tanzania. Trop Med Int Health 9: 262-266.
25. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S, Enquete Perinatale Francaise Study Group (2003) Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17: 2053-2061.
26. Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, et al. (2005) Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 94: 1571-1577.
27. Feiterna-Sperling C, Weizsaecker K, Bührer C (2007) Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr 45(1): 43-51.
28. Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, et al. (2011) Increased risk of severe infant anemia following exposure to maternal HAART, Botswana. J AIDS 56(5): 428-436.